Characterization of IL-10-secreting T cells derived from regulatory CD4+CD25+ cells by the TIRC7 surface marker

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 6054-6063

  Wakkach, Abdelilah ^a   Augier, Séverine ^a   Breittmayer, Jean Philippe ^b   Blin Wakkach, Claudine ^a   Carle, Georges F ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MEMBRANE PROTEIN; PROTEIN TIRC7; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; ATP6AP1 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MEMBRANE ANTIGEN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEADY STATE; T LYMPHOCYTE ACTIVATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; EXPERIMENTAL NEOPLASM; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; REGULATORY T LYMPHOCYTE; SECRETION;

ANIMALS; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNE TOLERANCE; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES, REGULATORY; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 44449131015     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.6054     Document Type: Article

References (44)

1. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
2. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
3. Asano, M., M. Toda, N. Sakaguchi, and S. Sakaguchi. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184: 387-396. (Pubitemid 26324092)
4. Jiang, H., and L. Chess. 2004. An integrated view of suppressor T cell subsets in immunoregulation. J. Clin. Invest. 114: 1198-1208. (Pubitemid 40385287)
5. O'Garra, A., and P. Vieira. 2004. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10: 801-805. (Pubitemid 39070850)
6. + T regulatory cells. Nat. Immunol. 4: 337-342.
7. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
8. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341. (Pubitemid 40387475)
9. Fontenot, J. D., and A. Y. Rudensky. 2005. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6: 331-337. (Pubitemid 41716769)
10. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med. 201: 779-791.
11. + natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203: 777-788.
12. Utku, N., T. Heinemann, S. G. Tullius, G. C. Bulwin, S. Beinke, R. S. Blumberg, F. Beato, J. Randall, R. Kojima, L. Busconi, et al. 1998. Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Immunity 9: 509-518. (Pubitemid 28499202)
13. Li, Y. P., W. Chen, Y. Liang, E. Li, and P. Stashenko. 1999. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23: 447-451.
14. Scimeca, J. C., A. Franchi, C. Trojani, H. Parrinello, J. Grosgeorge, C. Robert, O. Jaillon, C. Poirier, P. Gaudray, and G. F. Carle. 2000. The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26: 207-213. (Pubitemid 30101642)
15. Blin-Wakkach, C., A. Wakkach, P. M. Sexton, N. Rochet, and G. F. Carle. 2004. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis. Leukemia 18: 1505-1511. (Pubitemid 39264073)
16. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25: 402-408. (Pubitemid 34164012)
17. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198: 235-247.
18. Wakkach, A., N. Fournier, V. Brun, J. P. Breittmayer, F. Cottrez, and H. Groux. 2003. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18: 605-617. (Pubitemid 36588578)
19. Chiodoni, C., P. Paglia, A. Stoppacciaro, M. Rodolfo, M. Parenza, and M. P. Colombo. 1999. Dendritic cells infiltrating tumors cotransduced with granulocyte/ macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J. Exp. Med. 190: 125-133. (Pubitemid 29330129)
20. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192: 295-302.
21. + regulatory T cells constitutively expressing cytotoxic T lymphocyte- associated antigen 4. J. Exp. Med. 192: 303-310.
22. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
23. Powrie, F., M. W. Leach, S. Mauze, S. Menon, L. B. Caddle, and R. L. Coffman. 1994. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells. Immunity 1: 553-562. (Pubitemid 2156906)
24. + regulatory T cells. J. Immunol. 170: 3939-3943.
25. Zou, W. 2006. Regulatory T cells, tumour immunity, and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
26. Beyer, M., and J. L. Schultze. 2006. Regulatory T cells in cancer. Blood 108: 804-811. (Pubitemid 44154611)
27. Colombo, M. P., M. Vagliani, F. Spreafico, M. Parenza, C. Chiodoni, C. Melani, and A. Stoppacciaro. 1996. Amount of interleukin 12 available at the tumor site is critical for tumor regression. Cancer Res. 56: 2531-2534. (Pubitemid 26170689)
28. + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol. Rev. 182: 18-32.
29. Wakkach, A., F. Cottrez, and H. Groux. 2001. Differentiation of regulatory T cells 1 is induced by CD2 costimulation. J. Immunol. 167: 3107-3113. (Pubitemid 32852548)
30. Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50. (Pubitemid 44116698)
31. + suppressor T cells. Novartis Found. Symp. 252: 24-44, 106-114.
32. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166: 3008-3018.
33. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004. (Pubitemid 29480828)
34. + regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
35. + T cells during cure of colitis. J. Immunol. 177: 5852-5860.
36. Jump, R. L., and A. D. Levine. 2002. Murine Peyer's patches favor development of an IL-10-secreting, regulatory T cell population. J. Immunol. 168: 6113-6119. (Pubitemid 34620028)
37. + T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199: 1479-1489.
38. Hesse, M., C. A. Piccirillo, Y. Belkaid, J. Prufer, M. Mentink-Kane, M. Leusink, A. W. Cheever, E. M. Shevach, and T. A. Wynn. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172: 3157-3166. (Pubitemid 38263706)
39. Battaglia, M., A. Stabilini, E. Draghici, S. Gregori, C. Mocchetti, E. Bonifacio, and M. G. Roncarolo. 2006. Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55: 40-49. (Pubitemid 43343297)
40. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195: 603-616.
41. + regulatory T cells. J. Immunol. 172: 5986-5993.
42. + and type 1 regulatory T cells. Curr. Top Microbiol. Immunol. 293: 303-326.
43. Utku, N., A. Boerner, A. Tomschegg, F. Bennai-Sanfourche, G. C. Bulwin, T. Heinemann, J. Loehler, R. S. Blumberg, and H. D. Volk. 2004. TIRC7 defi- ciency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response. J. Immunol. 173: 2342-2352. (Pubitemid 39063090)
44. - precursor cells in the absence of interleukin 10. Nat. Immunol. 9: 931-941.